arrow_back Trending Legislation
Share share

Mandatory Electronic Prescribing for Controlled Substances in Health Plans by 2025

This Act mandates that starting January 1, 2025, group and individual health plans must require participating providers to electronically transmit prescriptions for Schedule II-V controlled substances. The goal is to enhance safety and reduce fraud related to these medications. Crucially, the law includes exceptions for technological failures, hospice care, and public health emergencies, ensuring that valid non-electronic prescriptions are still covered and dispensed by pharmacies.
Key points
Health plans must enforce electronic prescribing for controlled substances (Schedules II-V) by participating doctors starting January 1, 2025.
Exceptions apply for patients in hospice care, nursing facilities, or during temporary technical outages, allowing non-electronic prescriptions in these cases.
Insurers cannot deny coverage or reimbursement for a valid prescription solely because it was issued in a non-electronic format under an allowed exception.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
EPCS 2.0 Act
Print number: S 2666
Sponsor: Sen. Hassan, Margaret Wood [D-NH]
Process start date: 2023-07-27
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Mandatory Electronic Prescribing for Controlled Substances in Health Plans by 2025

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 2666.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-07-27.

What are the main provisions?

Key points include:

  • Health plans must enforce electronic prescribing for controlled substances (Schedules II-V) by participating doctors starting January 1, 2025.
  • Exceptions apply for patients in hospice care, nursing facilities, or during temporary technical outages, allowing non-electronic prescriptions in these cases.
  • Insurers cannot deny coverage or reimbursement for a valid prescription solely because it was issued in a non-electronic format under an allowed exception.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hassan, Margaret Wood [D-NH].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of S 2666

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health